BALF_logo_2014_white_blue bckgd_vertical.png
Bay Area Lyme Foundation Funds $8M in Tick-borne Disease Research During the Pandemic
January 25, 2022 12:17 ET | Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced that the organization has raised more than...
Image
Lyme Disease Advocacy Organization Meets With FDA
October 26, 2021 10:00 ET | TruthCures
BOSTON, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Nonprofit grassroots organization TruthCures met with Food & Drug Administration (FDA) officials Monday, Oct. 18, 2021 to discuss issues related to...
vmr logo TM.png
Hyperbaric Oxygen Therapy Market size worth $ 4.79 Billion, Globally, by 2028 at 6.24% CAGR: Verified Market Research®
September 23, 2021 10:00 ET | Verified Market Research
Jersey City, New Jersey, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Hyperbaric Oxygen Therapy Market” By Product Type (Monoplace HBOT, Topical HBOT,...
tarsus-logo-stacked-color-532x626.png
Tarsus Pharmaceuticals, Inc. Initiates Phase 1 Callisto Trial of TP-05, a Novel, Oral, Non-Vaccine Therapeutic for the Prevention of Lyme Disease
June 16, 2021 16:05 ET | Tarsus Pharmaceuticals, Inc
More than 30 million Americans at risk for Lyme disease exposure, which can result in severe neurological and other debilitating symptoms First participants dosed in single ascending dose and...
Tarsus_Logo_Parnership_Announcement.jpg
Tarsus Pharmaceuticals, Inc. Announces FDA Acceptance of Investigational New Drug Application for TP-05 for Lyme Disease Prevention
May 04, 2021 16:05 ET | Tarsus Pharmaceuticals, Inc
Novel candidate in development aims to be first approved non-vaccine therapeutic for Lyme disease prevention Allows initiation of Phase 1 study to evaluate safety, pharmacokinetics, and dosing More...
Traditional Naturopath Shares Inspiring Journey to Healing from Addiction, Chronic Illness in Debut Memoir
January 19, 2021 07:00 ET | Balboa Press
GIBSON, La., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Author and traditional naturopath Michelle L. Potter has published her uplifting memoir that invites readers to share in Potter’s persistence and...
FCL.png
Lui Franciosi of Franciosi Consulting Launches YouTube Channel
December 22, 2020 19:37 ET | Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is proud to announce the launch of his new YouTube channel. As a pharmacologist and former executive in the...
FCL.png
Lui Franciosi Launches New Business Website
December 22, 2020 19:07 ET | Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is proud to announce the launch of a new business website for his company, Franciosi Consulting Ltd. Franciosi Consulting...
Witness a true story of long-term suffering with chronic illness, addiction and Lyme disease transformed by the will to live
November 10, 2020 01:27 ET | Balboa Press
GIBSON, La., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Despite the debilitating pain, discomfort and mysterious symptoms that Michelle L. Potter had since childhood, doctors kept telling that there is...
lymemind-logo-CMYK_full-color.jpg
LymeMIND, a division of the Icahn School of Medicine at Mount Sinai, to Host LymeMIND 2020 Virtual Conference on October 10
September 09, 2020 09:00 ET | LymeMIND
NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- LymeMIND, the data coordination center of the Cohen Lyme & Tickborne Disease Initiative, housed at the Icahn School of Medicine at Mount Sinai, today...